Neil Bell

Chief Development Officer at Avacta Life Sciences

About

Bell oversees pre-clinical and early clinical development of the company’s pre|CISION pro-drugs and Affimer immunotherapies


Bell has more than 30 years of expertise in drug development, with a number of senior roles in global pharmaceuticals and biotech companies. He most recently served as Senior Vice President, Head of Global Clinical Operations at cell and gene therapy company Autolus.

Timeline

  • Chief Development Officer

    Current role

View in org chart